Mr. Hylton Karon reports

IFABRIC ANNOUNCES PUBLICATION OF GROUNDBREAKING CLINICAL TRIAL PROVING THE INFECTION CONTROL ABILITY OF PROTX2 AND ECOPEL TREATED SCRUBS

The results of iFabric Corp.'s clinical trial, "Antimicrobial-treated fabric scrubs can prevent pathogen proliferation on scrubs," have been officially published in the Journal of Hospital Infection, the editorially independent scientific publication of the Healthcare Infection Society. The aim of the journal is to publish high-quality research and information relating to infection prevention and control that are relevant to an international audience.

The study -- conducted by subsidiary Intelligent Fabric Technologies (North America) Inc. at MemorialCare Saddleback Medical Center in Southern California under the leadership of Cheryl Westlake, PhD, RN, ACNS-BC, FHFSA, FAHA, FAAN; Kathleen M. Young, MSN, RN, NPD-BC; Brandi Cassingham, MSN, RN; and Lisa Forsythe, MSN-Ed, RN, NPD-BC -- marks the first successful anti-microbial textile trial of its kind to demonstrate statistically significant reductions in bacterial loads on scrubs worn in a real-world health care setting.

"Previous attempts using other anti-microbial chemistries have failed to produce results of this magnitude. This trial conclusively showed that scrubs treated with Protx2 and Protx2 combined with our ecoPEL fluorine-free durable water repellent technology achieved significant and quantifiable reductions in surface bacterial contamination compared to untreated scrubs -- proof that these proprietary technologies can deliver infection control performance unmatched in the industry," said Giancarlo Beevis, president and chief executive officer of IFTNA.

"This is an extraordinary moment for IFTNA. For decades, infection prevention experts have looked for textile-based solutions that could truly reduce bacterial contamination in real-world hospital environments. Until now, no trial has achieved this level of measurable infection control benefits," added Mr. Beevis.

"I believe that this publication has the potential to draw the attention of some of the most respected leaders in infection prevention across the USA and globally, and positions Protx2 as a cornerstone solution in the fight against health-care-associated infections, providing a significant market opportunity for IFTNA. This study positions IFTNA at the forefront of that opportunity, with the ability to deliver performance-driven textile technologies at scale," concluded Mr. Beevis.

Protx2 is currently registered with the U.S. Environmental Protection Agency and is freely available for use throughout the United States.

Potential benefits of Protx2 and ecoPEL in infection prevention:

• Reduced infection rates: By minimizing pathogen transfer between patients and health care staff, treated scrubs can play a key role in lowering hospital-acquired infection rates.
• Decreased readmissions: Fewer infections mean fewer costly patient readmissions, improving overall patient outcomes.
• Lower hospital costs: The potential economic savings for health care facilities are substantial, both in direct treatment costs and in reduced staffing disruptions.
• Protection beyond the hospital: Treated scrubs also reduce bacterial spread into homes and communities, enhancing public health far beyond the ward.

About iFabric Corp.

Headquartered in Markham, Ont., iFabric is listed on the Toronto Stock Exchange and currently has 30.3 million shares issued and outstanding. Its two strategic divisions offer a variety of products and services through wholly owned subsidiaries, namely Intelligent Fabric Technologies (North America) Inc. and Coconut Grove Pads Inc.

IFTNA is focused on development and sale of high performance sports apparel, medical protective apparel, consumer protective apparel and proprietary treatments that provide intelligent properties to fabrics, foams, plastics and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include anti-viral and anti-bacterial characteristics, water repellence, and ultraviolet protection, among others.

Coconut Grove, operating as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies intimate apparel products and accessories.

We seek Safe Harbor.